These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Shin SJ, Huitt GA, Daley CL, Kwon OJ. Am J Respir Crit Care Med; 2011 Feb 01; 183(3):405-10. PubMed ID: 20833823 [Abstract] [Full Text] [Related]
5. Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy. Kim HS, Lee KS, Koh WJ, Jeon K, Lee EJ, Kang H, Ahn J. Radiology; 2012 Apr 01; 263(1):260-70. PubMed ID: 22371609 [Abstract] [Full Text] [Related]
6. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex. Shin SH, Jhun BW, Kim SY, Choe J, Jeon K, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. Antimicrob Agents Chemother; 2018 Oct 01; 62(10):. PubMed ID: 30104265 [Abstract] [Full Text] [Related]
7. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. Jeong SH, Kim SY, Huh HJ, Ki CS, Lee NY, Kang CI, Chung DR, Peck KR, Shin SJ, Koh WJ. Int J Infect Dis; 2017 Jul 01; 60():49-56. PubMed ID: 28522316 [Abstract] [Full Text] [Related]
8. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense. Zhang Z, Lu J, Liu M, Wang Y, Zhao Y, Pang Y. Int J Antimicrob Agents; 2017 Mar 01; 49(3):383-386. PubMed ID: 28188830 [Abstract] [Full Text] [Related]
9. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease. Fujiwara K, Uesugi F, Furuuchi K, Tanaka Y, Yoshiyama T, Saotome M, Ohta K, Mitarai S, Morimoto K. Microbiol Spectr; 2021 Dec 22; 9(3):e0192821. PubMed ID: 34878300 [Abstract] [Full Text] [Related]
10. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, Pin I, Sermet I, Gutierrez C, Véziris N, Jarlier V, Cambau E, Herrmann JL, Guillemot D, Gaillard JL, OMA group. J Cyst Fibros; 2015 Jan 22; 14(1):63-9. PubMed ID: 25085077 [Abstract] [Full Text] [Related]
11. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense. Chu HS, Chang SC, Shen EP, Hu FR. PLoS One; 2015 Jan 22; 10(1):e0116236. PubMed ID: 25581038 [Abstract] [Full Text] [Related]
12. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Choi GE, Shin SJ, Won CJ, Min KN, Oh T, Hahn MY, Lee K, Lee SH, Daley CL, Kim S, Jeong BH, Jeon K, Koh WJ. Am J Respir Crit Care Med; 2012 Nov 01; 186(9):917-25. PubMed ID: 22878281 [Abstract] [Full Text] [Related]
13. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, Liu PY, Shi ZY. J Microbiol Immunol Infect; 2010 Oct 01; 43(5):401-6. PubMed ID: 21075707 [Abstract] [Full Text] [Related]
14. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report. Kim SY, Shin SJ, Jeong BH, Koh WJ. BMC Infect Dis; 2016 May 17; 16():207. PubMed ID: 27188784 [Abstract] [Full Text] [Related]
15. Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease. Im Y, Kim SY, Kim DH, Jhun BW. Chest; 2024 Feb 17; 165(2):288-302. PubMed ID: 37661004 [Abstract] [Full Text] [Related]
16. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus]. Nie W, Duan H, Huang H, Lu Y, Chu N. Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul 17; 37(7):517-21. PubMed ID: 25262693 [Abstract] [Full Text] [Related]
17. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea. Kim SY, Kim CK, Bae IK, Jeong SH, Yim JJ, Jung JY, Park MS, Kim YS, Kim SK, Chang J, Kang YA. Diagn Microbiol Infect Dis; 2015 Feb 17; 81(2):107-11. PubMed ID: 25467784 [Abstract] [Full Text] [Related]
18. The treatment of rapidly growing mycobacterial infections. Kasperbauer SH, De Groote MA. Clin Chest Med; 2015 Mar 17; 36(1):67-78. PubMed ID: 25676520 [Abstract] [Full Text] [Related]
19. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Koh WJ. Am J Respir Crit Care Med; 2009 Nov 01; 180(9):896-902. PubMed ID: 19661243 [Abstract] [Full Text] [Related]
20. [Clinical characteristics of 42 patients with different subspecies of Mycobacterium abscessus complex pulmonary disease]. He SQ, Chen PR, Chen H. Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec 12; 46(12):1228-1232. PubMed ID: 38044050 [Abstract] [Full Text] [Related] Page: [Next] [New Search]